Cell cycle-dependent distribution and specific inhibitory effect of vectorized antisense oligonucleotides in cell culture

Biochemical Pharmacology

Volumn 58, Issue 1, 1999, Pages 95-107

  Hélin, Valérie ^a   Gottikh, Marina ^a,b   Mishal, Zohar ^c   Subra, Frédéric ^a   Malvy, Claude ^a   Lavignon, Marc ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c CNRS   (France)

Author keywords

Antisense oligodeoxynucleotide; Cell cycle, screening system; Intracellular distribution; Polyamidoamine dendrimer

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; DENDRIMER; DRUG CARRIER; GREEN FLUORESCENT PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; CELL CYCLE; CELL STRAIN 3T3; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE;

3T3 CELLS; ANIMALS; CELL CULTURE TECHNIQUES; CELL CYCLE; FLOW CYTOMETRY; GENE EXPRESSION; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; KINETICS; LUMINESCENT PROTEINS; MICE; MICROSCOPY, CONFOCAL; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER;

EID: 0033169076     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00083-0     Document Type: Article

References (54)

1. Akhtar S., Agrawal S. In vivo studies with antisense oligonucleotides. Trends Pharmacol Sci. 18:1997;12-18.
2. Bennett C.F. Antisense oligonucleotides Is the glass half full or half empty? Biochem Pharmacol. 55:1998;9-19.
3. Skorski T., Nieborowska-Skorska M., Barletta C., Malaguarnera L., Szcyzlik C., Chen S.T., Lange B., Calabretta B. Highly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl antisense oligodeoxynucleotides combined with mafosfamide. J Clin Invest. 92:1993;194-202.
4. Bishop M.R., Iversen P.L., Bayever E., Sharp J.G., Greiner T.C., Copple B.L., Ruddon R., Zon G., Spinolo J., Anerson M., Armitage J.O., Kessinger A. Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies. J Clin Oncol. 14:1996;1320-1326.
5. Monia P.B., Johnston J.F., Geiger T., Muller M., Fabbro D. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat Med. 2:1996;668-675.
6. Offensperger W.B., Offensperger S., Walter E., Teubner K., Igloi G., Blum H.E., Gerok W. In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate-modified antisense oligodeoxynucleotides. EMBO J. 12:1993;1257-1262.
7. Lisziewicz J., Sun D., Weichold F.F., Thierry A.R., Lusso P., Tang J., Gallo R.C., Agrawal S. Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells. Proc Natl Acad Sci USA. 91:1994;7942-7946.
8. Azad R.F., Brown-Driver V., Buckheit R.W., Anderson K.P. Antiviral activity of a phophorothioate oligonucleotide complementary to human cytomegalovirus RNA when used in combination with antiviral nucleoside analogs. Antivir Res. 28:1995;101-111.
9. Uhlmann E., Peyman A. Antisense oligonucleotides A new therapeutic principle . Chem Rev. 90:1990;544-584.
10. Gray G.D., Basu S., Wickstrom E. Transformed and immortalized cellular uptake of oligodeoxynucleoside phosphorothioates, 3′-alkylamino oligodeoxynucleotides, 2′-O-methyl oligoribonucleotides, oligodeoxynucleoside methylphosphonates, and peptide nucleic acids. Biochem Pharmacol. 53:1997;1465-1476.
11. Wagner R.W., Matteucci M.D., Lewis J.G., Gutierrez A.J., Moulds C., Froehler B.C. Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science. 260:1993;1510-1513.
12. Stein C.A., Tonkinson J.L., Yakubov L. Phosphorothioate oligodeoxynucleotides-antisense inhibitors of gene expression? Pharmacol Ther. 52:1991;365-384.
13. Boutorin A.S., Gus'kova L.V., Ivanova E.M., Kobetz N.D., Zarytova V.F., Ryte A.S., Yurchenko L.V., Vlassov V.V. Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3′-terminus and their interaction with DNA within mammalian cells. FEBS Lett. 254:1989;129-132.
14. Boutorine A.S., Kostina E.V. Reversible covalent attachment of cholesterol to oligodeoxyribonucleotides for studies of the mechanisms of their penetration into eucaryotic cells. Biochimie. 75:1993;35-41.
15. Krieg A.M., Tonkinson J., Matson S., Zhao Q., Saxon M., Zhang L.M., Bhanja U., Yakubov L., Stein C.A. Modification of antisense phosphodiester oligodeoxynucleotides by a 5′ cholesteryl moiety increases cellular association and improves efficacy. Proc Natl Acad Sci USA. 90:1993;1048-1052.
16. Asseline U., Hau J.F., Czernecki S., Le Diguarher T., Perlat M.C., Valery J.M., Thuong M.T. Synthesis and physicochemical properties of oligonucleotides built with either alpha-L or beta-L nucleotide units and covalently linked to an acridine derivative. Nucleic Acids Res. 19:1991;4067-4074.
17. Bongartz J.P., Aubertin A.M., Milhaud P.G., Lebleu B. Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide. Nucleic Acids Res. 22:1994;4681-4688.
18. Morris M.C., Vidal P., Chaloin L., Heitz F., Divita G. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res. 25:1997;2730-2736.
19. Akhtar S., Juliano R.L. Liposome delivery of antisense oligonucleotides Adsorption and efflux characteristics of phosphorothioate oligodeoxynucleotides . J Control Release. 22:1992;47-56.
20. Ropert C., Lavignon M., Dubernet C., Couvreur P., Malvy C. Oligonucleotides encapsulated in pH-sensitive liposomes are efficient toward Friend retrovirus. Biochem Biophys Res Commun. 183:1992;879-885.
21. Leonetti J.P., Machy P., Degols G., Lebleu B., Lesserman L. Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replication. Proc Natl Acad Sci USA. 87:1990;2448-2451.
22. Zelphati O., Imbach J.L., Signoret N., Zon G., Rayner B., Leserman L. Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms. Nucleic Acids Res. 22:1994;4307-4314.
23. Chavany C., Saison-Behmoaras T., Le Doan T., Puiseux F., Couvreur P., Hélène C. Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake. Pharmacol Res. 11:1994;1370-1378.
24. Schwab G., Chavany C., Duroux I., Goubin G., Lebeau J., Hélène C., Saison-Behmoaras T. Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice. Proc Natl Acad Sci USA. 91:1994;10460-10464.
25. Degols G., Leonetti J.P., Benkirane M., Devaux C., Lebleu B. Poly(L-lysine)-conjugated oligonucleotides promote sequence-specific inhibition of acute HIV-1 infection. Antisense Res Dev. 2:1992;293-301.
26. Bennett C.F., Chiang M.Y., Chan H., Shomaker J.E., Mirabelli C.K. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol. 41:1992;1023-1033.
27. Capaccioli S., Di Pasquale G., Mini E., Mazzei T., Quatrone A. Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. Biochem Biophys Res Commun. 197:1993;818-825.
28. Zelphati O., Szoka F.C. Jr. Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids. Pharmacol Res. 13:1996;1367-1372.
29. Lewis J.G., Lin K.Y., Kothavale A., Flanagan W.M., Matteucci M.D., Deprince R.B., Mook R.A. Jr, Hendren R.W., Wagner R.W. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc Natl Acad Sci USA. 93:1996;3176-3181.
30. Goldman C.K., Soroceanu L., Smith N., Gillepsie G.Y., Shaw W., Burgess S., Bilbao G., Curiel D.T. In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer. Nat Biotechnol. 15:1997;462-466.
31. Mahato R.I., Takemura S., Akamatsu K., Nishikawa M., Takakura Y., Hashida M. Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine). Biochem Pharmacol. 53:1997;887-895.
32. Kukowska-Latallo J.F., Bielinska A.U., Johnson J., Spindler R., Tomalia D.A., Baker J.R. Jr. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad Sci USA. 93:1996;4897-4902.
33. Tang M.X., Redemann C.T., Szoka F.C. Jr. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjugate Chem. 7:1996;703-714.
34. Poxon S.W., Mitchell P.M., Liang E., Hughes J.A. Dendrimer delivery of oligonucleotides. Drug Deliv. 3:1996;255-261.
35. Delong R., Stephenson K., Loftus T., Fisher M., Alahari S., Nolting A., Juliano R.L. Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimer effects on intracellular delivery. J Pharm Sci. 86:1997;762-764.
36. Bielinska A., Kulowska-Latallo J.F., Johnson J., Tomalia D.A., Baker J.R. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res. 24:1996;2176-2182.
37. Hughes J.A., Aronsohn A.I., Avrutskaya A.V., Juliano R.L. Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides. Pharm Res. 13:1996;404-410.
38. Gregoire M., Hernandez-Verdun D., Bouteille M. Visualisation of chromatin distribution in living PTO cells by Hoechst 33342 fluorescent staining. Exp Cell Res. 152:1984;38-46.
39. Stein G.S., Stein J.L., Lian J.B., Last T.J., Owen T., McCabe L. Synchronization of normal diploid and transformed mammalian cells. Celis J., Cell biology A Laboratory Handbook . 1994;282-287 Academic Press, New York.
40. Misteli T., Spector D.L. Applications of the green fluorescent protein in cell biology and biotechnology. Nat Biotechnol. 15:1997;961-964.
41. Vistica D.T., Skehan P., Scudiero D., Monks A., Pittman A., Boyd M.R. Tetrazolium-based assays for cellular viability A critical examination of selected parameters affecting formazan production . Cancer Res. 51:1991;2515-2520.
42. Loke S.L., Stein C.A., Zhang X.H., Mori K., Nakanishi M., Subasinghe C., Cohen J.S., Neckers L.M. Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci USA. 86:1989;3474-3478.
43. Yakubov L.A., Deeva E.A., Zarytova V.F., Ivanova E.M., Ryte A.S., Yurchenko L.V., Vlassov V.V. Mechanism of oligonucleotide uptake by cells Involvement of specific receptors? Proc Natl Acad Sci USA. 86:1989;6454-6458.
44. Stein C.A., Tonkinson J.L., Zhang L.M., Yakubov L., Gervasoni J., Taub R., Rotenberg S.A. Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells. Biochemistry. 32:1993;4855-4861.
45. Tonkinson J.L., Stein C.A. Patterns of intracellular compartmentalization, trafficking and acidification of 5′-fluorescein-labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells. Nucleic Acids Res. 22:1994;4268-4275.
46. Wu-Pong S., Bard J., Huffman J., Jimerson J. Oligonucleotide biological activity Relationship to the cell cycle and nuclear transport . Biol Cell. 89:1997;257-261.
47. Zamecnik P., Aghajanian J., Zamecnik M., Goodchild J., Witman G. Electron micrographic studies of transport of oligodeoxynucleotides across eukaryotic cell membranes. Proc Natl Acad Sci USA. 91:1994;3156-3160.
48. Zhao Q., Song X., Waldschmidt T., Fisher E., Krieg A.M. Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation. Blood. 88:1996;1788-1795.
49. Krieg A.M., Gmelig-Meyling F., Gourley M.F., Kisch W.J., Chrisey L.A., Steinberg A.D. Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible. Antisense Res Dev. 1:1991;161-171.
50. Giles R.V., Ruddell C.J., Spiller D.G., Green J.A., Tidd D.M. Single base discrimination for ribonuclease H-dependent antisense effects within intact human leukaemia cells. Nucleic Acids Res. 23:1995;954-961.
51. Moulds C., Lewis J.G., Froehler B.C., Grant D., Huang T., Milligan J.F., Matteuci M.D., Wagner R.W. Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides. Biochemistry. 34:1995;5044-5053.
52. Monia B.P., Johnston J.F., Ecker D.J., Zounes M.A., Lima W.F., Freier S.M. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J Biol Chem. 267:1992;19954-19962.
53. Butler M., Stecker K., Bennett C.F. Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues. Lab Invest. 77:1997;379-388.
54. Moulds C., Lewis J.G., Froehler B.C., Grant D., Huang T., Milligan J.F., Matteucci M.D., Wagner R.W. Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides. Biochemistry. 34:1995;5044-5053.